Key result
High Hospital Frailty Risk Score (HFRS) was associated with increased 30-day in-patient mortality (aOR 1.38; 95% CI 1.35-1.42) and prolonged length of stay, but not 30-day readmissions.
Why the study?
The Hospital Frailty Risk Score can identify frailty subgroups using routinely collected hospital data, but it required external validation in France.
Does the Hospital Frailty Risk Score predict 30-day in-patient mortality, prolonged length of stay, and 30-day readmissions in older patients hospitalized as an emergency?
Cohort (n=1,042,234)
Yes
Does the Hospital Frailty Risk Score predict 30-day in-patient mortality, prolonged length of stay, and 30-day readmissions in older patients hospitalized as an emergency?
The Hospital Frailty Risk Score is a valid tool for predicting 30-day in-patient mortality and prolonged length of stay, but not 30-day readmissions, among older emergency admissions in France.
BACKGROUND: The Hospital Frailty Risk Score (HFRS) has made it possible internationally to identify subgroups of patients with characteristics of frailty from routinely collected hospital data. OBJECTIVE: To externally validate the HFRS in France. DESIGN: A retrospective analysis of the French medical information database. SETTING: 743 hospitals in Metropolitan France. SUBJECTS: All patients aged 75 years or older hospitalised as an emergency in 2017 (n = 1,042,234). METHODS: The HFRS was calculated for each patient based on the index stay and hospitalisations over the preceding 2 years. Main outcome measures were 30-day in-patient mortality, length of stay (LOS) >10 days and 30-day readmissions. Mixed logistic regression models were used to investigate the association between outcomes and HFRS score. RESULTS: Patients with high HFRS risk were associated with increased risk of mortality and prolonged LOS (adjusted odds ratio [aOR] = 1.38 [1.35-1.42] and 3.27 [3.22-3.32], c-statistics = 0.676 and 0.684, respectively), while it appeared less predictive of readmissions (aOR = 1.00 [0.98-1.02], c-statistic = 0.600). Model calibration was excellent. Restricting the score to data prior to index admission reduced discrimination of HFRS substantially. CONCLUSIONS: HFRS can be used in France to determine risks of 30-day in-patient mortality and prolonged LOS, but not 30-day readmissions. Trial registration: Reference ID on clinicaltrials.gov: ID: NCT03905629.
No takes yet. Share an insight, caveat, or question.
Gilbert et al. (2021) conducted a cohort in Frailty (n=1,042,234). Hospital Frailty Risk Score (HFRS) was evaluated on 30-day in-patient mortality, length of stay (LOS) >10 days and 30-day readmissions (aOR 1.38, 95% CI 1.35-1.42). High Hospital Frailty Risk Score (HFRS) was associated with increased 30-day in-patient mortality (aOR 1.38; 95% CI 1.35-1.42) and prolonged length of stay, but not 30-day readmissions.
Synapse has enriched 5 related papers. Consider them for comparative context: